Fresenius Medical Care AG當前公司基本面數據相對健康,增長潛力很大。當前估值合理,在醫療服務供應商行業排名47/78位。機構持股佔比非常高,近一個月多位分析師給出公司評級為持有。最高目標價28.05。中期看,股價處於平穩狀態。近一個月,市場表現一般,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。
Fresenius Medical Care AG評分
相關信息
行業排名
47 / 78
全市場排名
216 / 4582
所屬行業
醫療服務供應商
壓力支撐
由於公司未披露,未能獲取相關數據
多維評測
本期評分
上期評分
分析師目標
基於
7
分析師
持有
評級
28.046
目標均價
+22.85%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議
Fresenius Medical Care AG亮點
亮點風險
Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD) and offers other extracorporeal therapies, as well as other healthcare services. It has two operating segments such as care delivery segment which consolidates the global health care services business and care enablement segment includes research and development (R&D), manufacturing, supply chain, and commercial operations. It develops and manufactures health care products, which includes dialysis and non-dialysis products. Such as hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. It owns, operates, or manages dialysis clinics sells products to other dialysis providers.
Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD) and offers other extracorporeal therapies, as well as other healthcare services. It has two operating segments such as care delivery segment which consolidates the global health care services business and care enablement segment includes research and development (R&D), manufacturing, supply chain, and commercial operations. It develops and manufactures health care products, which includes dialysis and non-dialysis products. Such as hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. It owns, operates, or manages dialysis clinics sells products to other dialysis providers.
公司代碼FMS
公司Fresenius Medical Care AG
CEOCordola (Craig)
網址https://www.freseniusmedicalcare.com/
常見問題
Fresenius Medical Care AG(FMS)的當前股價是多少?
Fresenius Medical Care AG(FMS)的當前股價是 23.515。
Fresenius Medical Care AG 的股票代碼是什麼?
Fresenius Medical Care AG的股票代碼是FMS。
Fresenius Medical Care AG股票的52週最高點是多少?
Fresenius Medical Care AG股票的52週最高點是30.460。
Fresenius Medical Care AG股票的52週最低點是多少?
Fresenius Medical Care AG股票的52週最低點是22.050。
Fresenius Medical Care AG的市值是多少?
Fresenius Medical Care AG的市值是6.82B。
Fresenius Medical Care AG的淨利潤是多少?
Fresenius Medical Care AG的淨利潤為581.79M。
現在Fresenius Medical Care AG(FMS)的股票是買入、持有還是賣出?
根據分析師評級,Fresenius Medical Care AG(FMS)的總體評級為持有,目標價格為28.046。
Fresenius Medical Care AG(FMS)股票的每股收益(EPS TTM)是多少
Fresenius Medical Care AG(FMS)股票的每股收益(EPS TTM)是1.359。